Acorah Software Products - Accounts Production 16.5.460 false true false true No description of principal activity 24 April 2023 30 April 2024 30 April 2024 14821571 L Reardon iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14821571 2023-04-23 14821571 2024-04-30 14821571 2023-04-24 2024-04-30 14821571 frs-core:CurrentFinancialInstruments 2024-04-30 14821571 frs-bus:PrivateLimitedCompanyLtd 2023-04-24 2024-04-30 14821571 frs-bus:FilletedAccounts 2023-04-24 2024-04-30 14821571 frs-bus:Micro-entities 2023-04-24 2024-04-30 14821571 frs-bus:AuditExempt-NoAccountantsReport 2023-04-24 2024-04-30 14821571 frs-bus:Director1 2023-04-24 2024-04-30
Registered number: 14821571
Studio 17 Health Hub Ltd
Unaudited Financial Statements
For The Year Ended 30 April 2024
Balance Sheet
Registered number: 14821571
2024
£
Fixed assets 35,154
Current assets 2,770
Creditors: Amounts Falling Due Within One Year (77,468 )
NET CURRENT LIABILITIES (74,698 )
TOTAL ASSETS LESS CURRENT LIABILITIES (39,544 )
Accruals and deferred income (1,056 )
NET LIABILITIES (40,600 )
CAPITAL AND RESERVES (40,600 )

Notes

1. General Information
Studio 17 Health Hub Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 14821571 . The registered office is 66 Rivermeads Avenue, Twickenham, TW2 5JQ.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1
1
For the year ending 30 April 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
L Reardon
Director
26/09/2025